| scholarly article | Q13442814 |
| P2093 | author name string | James D Stockand | |
| J Gary Meszaros | |||
| P2860 | cites work | Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. | Q46009276 |
| Protein kinase C contributes to desensitization of ANG II signaling in adult rat cardiac fibroblasts | Q46547594 | ||
| Oncogenic src, raf, and ras stimulate a hypertrophic pattern of gene expression and increase cell size in neonatal rat ventricular myocytes | Q47285549 | ||
| Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. | Q53922014 | ||
| Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure | Q57259661 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Role of SGK in mineralocorticoid-regulated sodium transport | Q30856915 | ||
| Induction of cardiac fibrosis by aldosterone | Q31405267 | ||
| Early aldosterone action: toward filling the gap between transcription and transport | Q33731974 | ||
| Pleiotropic action of aldosterone in epithelia mediated by transcription and post-transcription mechanisms | Q33888847 | ||
| New ideas about aldosterone signaling in epithelia | Q34552939 | ||
| Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system | Q35994833 | ||
| Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice | Q36146023 | ||
| Characterization of early aldosterone-induced RNAs identified in A6 kidney epithelia | Q36864795 | ||
| Regulation of Na(+) reabsorption by the aldosterone-induced small G protein K-Ras2A. | Q38317867 | ||
| S-adenosyl-L-homocysteine hydrolase is necessary for aldosterone-induced activity of epithelial Na(+) channels | Q40786492 | ||
| Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. | Q40915594 | ||
| Isoprenylcysteine-O-carboxyl methyltransferase regulates aldosterone-sensitive Na(+) reabsorption | Q40929969 | ||
| Angiotensin II signalling pathways in cardiac fibroblasts: conventional versus novel mechanisms in mediating cardiac growth and function | Q41062589 | ||
| Mitogen-activated protein kinase (MAPK) in cardiac tissues | Q41062619 | ||
| Myofibroblasts and local angiotensin II in rat cardiac tissue repair | Q41391367 | ||
| Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between G(q) and G(s). | Q41715665 | ||
| Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts | Q41724668 | ||
| Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro | Q42518792 | ||
| Transient expression of the cloned mouse c-Ha-ras 5' upstream region in transfected primary SENCAR mouse keratinocytes demonstrates its power as a promoter element | Q43566828 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | H176-84 | |
| P577 | publication date | 2002-09-05 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling | |
| P478 | volume | 284 |
| Q30319286 | Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? |
| Q39244162 | Activation of ERK1/2 by NADPH oxidase-originated reactive oxygen species mediates uric acid-induced mesangial cell proliferation |
| Q92856771 | Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2 |
| Q45015877 | Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox-regulated mechanisms |
| Q57493008 | Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology |
| Q35770232 | Aldosterone and cardiovascular remodelling: focus on myocardial failure |
| Q54496164 | Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K/MAPK signalling. |
| Q35088073 | Aldosterone promotes cardiac endothelial cell proliferation in vivo. |
| Q33629543 | Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes |
| Q28570951 | Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy |
| Q46064901 | Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation |
| Q84504327 | Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts |
| Q24294309 | Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation |
| Q39300430 | Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications |
| Q41332447 | Blood Pressure and Atrial Fibrillation: A Combined AF-CHF and AFFIRM Analysis. |
| Q37705805 | COX-2/mPGES-1/PGE2 cascade activation mediates uric acid-induced mesangial cell proliferation |
| Q35071304 | Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor |
| Q39775299 | Cell migration in BeWo cells and the role of epithelial sodium channels |
| Q44886467 | Effect of aldosterone on renal transforming growth factor-beta |
| Q33962156 | Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction |
| Q36403245 | Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239. |
| Q38763624 | Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney |
| Q35554847 | Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report |
| Q38997782 | Evidence for aldosterone-dependent growth of renal cell carcinoma |
| Q35903075 | Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis |
| Q51273122 | Genomic and rapid effects of aldosterone: what we know and do not know thus far. |
| Q37623105 | Hypertension and atrial fibrillation |
| Q34981416 | Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans |
| Q54400972 | Inhibitory effect of ethyl acetate extract of Aristolochia yunnanensis on cardiac fibrosis through extracellular signal-regulated kinases 1/2 and transforming growth factor β/small mother against decapentaplegic signaling pathways. |
| Q36981091 | Ion channel regulation by Ras, Rho, and Rab small GTPases. |
| Q35636530 | Matrix metalloproteinases: pathways of induction by bioactive molecules |
| Q36674142 | Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. |
| Q41714003 | Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways? |
| Q26825697 | Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities |
| Q35207786 | Rapid aldosterone actions: from the membrane to signaling cascades to gene transcription and physiological effects |
| Q44811028 | Regulation of Na+ transport by aldosterone: signaling convergence and cross talk between the PI3-K and MAPK1/2 cascades |
| Q35670580 | Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertension |
| Q28578104 | Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38‐MAPK and ERK1/2 |
| Q47980460 | T3 peptide, a fragment of tumstatin, stimulates proliferation and migration of cardiac fibroblasts through activation of Akt signaling pathway. |
| Q36885519 | TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis |
| Q53091886 | Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts. |
| Q99587532 | Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle? |
| Q38875774 | The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. |
| Q39203698 | The migratory capacity of human trophoblastic BeWo cells: effects of aldosterone and the epithelial sodium channel |
| Q36238325 | The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology |
| Q37230796 | Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease |
| Q42483614 | Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling |
| Q28077454 | Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease |
| Q38124318 | What do we actually know about the relationship between arterial hypertension and atrial fibrillation? |
Search more.